FDA Approves New Nasal Spray to Reverse Overdoses
TUESDAY, May 23, 2023 (HealthDay News) — The U.S. Food and Drug Administration on Monday approved a second nasal spray for reversing an opioid overdose. To be sold as Opvee, the spray contains the medication nalmefene hydrochloride and will be availa…
Learn MoreMany Parents Worry About Social Media’s Impact on Kids’ Body Image: Poll
TUESDAY, May 23, 2023 (HealthDay News) — About 7 in 10 American parents are concerned that social media trends related to appearance and editing apps and filters are harming their children’s body image, a new survey shows.Among those polled, about 69…
Learn MorePTSD, Other Mental Health Ills Haunt Gunshot Survivors
TUESDAY, May 23, 2023 (HealthDay News) — For people who survive gunshot wounds, the trauma may leave mental scars that worsen with time, a new study finds.Among 87 adults treated for gun injuries at a Wisconsin trauma center, many had worsening sympt…
Learn More‘Complex’ Genetic Links Between Marijuana Use, Psychiatric Ills
TUESDAY, May 23, 2023 (HealthDay News) — A subset of people may be at high risk for both psychiatric disorders and for using marijuana, based on their genetics, according to a new study. Researchers from the University of Oslo in Norway have found th…
Learn MoreEpkinly Granted Accelerated FDA Approval for Lymphoma
MONDAY, May 22, 2023 (HealthDay News) — The U.S. Food and Drug Administration has granted accelerated approval to Epkinly (epcoritamab-bysp) for relapsed or refractory diffuse large B-cell lymphoma (DLBCL), including DLBCL arising from indolent lymph…
Learn More1 in 5 U.S. Seniors Now Skip Meds Because of Cost
MONDAY, May 22, 2023 (HealthDay News) — Many seniors skip or stretch prescription medications due to costs despite being insured by Medicare, a new U.S. study finds. Roughly 20% of older adults reported taking less medication than prescribed or not t…
Learn MoreLa FDA aprueba la primera pastilla para tratar la enfermedad de Crohn de moderada a grave
VIERNES, 19 de mayo de 2023 (HealthDay News) — Los pacientes con enfermedad de Crohn cuentan ahora con una nueva opción de tratamiento, después de que la Administración de Alimentos y Medicamentos (FDA) de EE. UU. aprobara una pastilla llamada Rinvoq…
Learn MoreLas parejas de a partir de 55 años pronto podrán contribuir 10,000 dólares al año a una HSA
VIERNES, 19 de mayo de 2023 (HealthDay News) — Una nueva directriz del Departamento de Tesorería (IRS) permitirá a las parejas mayores de Estados Unidos contribuir más de 10,000 dólares a una cuenta de ahorros para la salud (HSA) libres de impuestos …
Learn MorePerceived Access to Firearms Higher in Teens With Depression, Suicidality
MONDAY, May 22, 2023 (HealthDay News) — High school-aged teens with recent depression and/or lifetime history of suicidality (DLHS) have higher perceived access to firearms than their peers without DLHS, according to a study published online May 22 i…
Learn More2011 to 2020 Saw Steady Improvement in Childhood Vaccine Adherence
MONDAY, May 22, 2023 (HealthDay News) — Adherence to national guidelines for childhood vaccination had been steadily improving before the COVID-19 pandemic, according to a study presented at the annual meeting of the Pediatric Academic Societies, hel…
Learn More